These findings highlighted that cognitive decline, as measured by objective neurocognitive tests in CP, has biological underpinnings in IGF-1 in a similar manner to that observed in older adults experiencing aging, MCI and AD. The gene discussed is IGF1; the disease is Mental deterioration.